Navigation Links
SemBioSys announces 2007 financial and operational results
Date:3/17/2008

------------ ------------

------------ ------------

SemBioSys Genetics Inc.

Consolidated Statements of Loss, Comprehensive Loss and Deficit

For the years ended December 31,

-------------------------------------------------------------------------

(expressed in Canadian dollars)

------------ ------------

2007 2006

------------ ------------

$ $

Revenue

Licensing fees 874,024 -

Contract research 122,304 523,258

Product sales 226,495 -

------------ ------------

1,222,823 523,258

Expenses

Research and development 8,044,121 5,480,972

General and administration 4,528,184 4,013,653

Intellectual property 1,569,095 3,467,045

Business development 1,213,634 745,964

Sales and marketing 201,094 -

Cost of products sold 198,019 -

Stock-based compensation 723,558 713,902

Amortization 1,390,065 832,845

Cost recoveries (267,995) (171,821)

------------ ------------

17,599,775 15,082
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
2. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
3. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys announces 2007 third quarter results
6. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
7. SemBioSys updates Apo AI development program
8. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
9. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
10. BioMed Realty Trust Announces Increase in Quarterly Common Stock Dividend
11. Emisphere Technologies, Inc. Announces Conference Call for 2007 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email: